Skip to main content

Advertisement

Log in

Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study

  • Imaging Informatics and Artificial Intelligence
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

To investigate whether pretreatment MRI-based radiomics of locally advanced rectal cancer (LARC) and/or the surrounding mesorectal compartment (MC) can predict pathologic complete response (pCR), neoadjuvant rectal (NAR) score, and tumor regression grade (TRG).

Methods

One hundred thirty-two consecutive patients with LARC who underwent neoadjuvant chemoradiation and total mesorectal excision (TME) were retrospectively collected from 2 centers in the USA and Italy. The primary tumor and surrounding MC were segmented on the best available T2-weighted sequence (axial, coronal, or sagittal). Three thousand one hundred ninety radiomic features were extracted using a python package. The most salient radiomic features as well as MRI parameter and clinical-based features were selected using recursive feature elimination. A logistic regression classifier was built to distinguish between any 2 binned categories in the considered endpoints: pCR, NAR, and TRG. Repeated k-fold validation was performed and AUCs calculated.

Results

There were 24, 87, and 21 T4, T3, and T2 LARCs, respectively (median age 63 years, 32 to 86). For NAR and TRG, the best classification performance was obtained using both the tumor and MC segmentations. The AUCs for classifying NAR 0 versus 2, pCR, and TRG 0/1 versus 2/3 were 0.66 (95% CI, 0.60–0.71), 0.80 (95% CI, 0.74–0.85), and 0.80 (95% CI, 0.77–0.82), respectively.

Conclusion

Radiomics of pretreatment MRIs can predict pCR, TRG, and NAR score in patients with LARC undergoing neoadjuvant treatment and TME with moderate accuracy despite extremely heterogenous image data. Both the tumor and MC contain important prognostic information.

Key Points

• Machine learning of rectal cancer on images from the pretreatment MRI can predict important patient outcomes with moderate accuracy.

• The tumor and the tissue around it both contain important prognostic information.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AJCC:

American Joint Commission on Cancer

CEA:

Carcinoembryonic antigen

CRM:

Circumferential resection margin

cT:

Clinical T stage

DFS:

Disease-free survival

LARC:

Locally advanced rectal cancer

MC:

Mesorectal compartment

mrTRG:

MRI tumor regression grade

NAR:

Neoadjuvant rectal (score)

OS:

Overall survival

pCR:

Pathologic complete response

TME:

Total mesorectal excision

TRG:

Tumor regression grade

ypN:

Posttreatment pathologic N stage

ypT:

Posttreatment pathologic T stage

References

  1. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics. CA Cancer J Clin 67:7–30

    Article  Google Scholar 

  2. Henley SJ, Singh SD, King J, Wilson RJ, O'Neil ME, Ryerson AB (2012) Invasive cancer incidence and survival--United States. MMWR Morb Mortal Wkly Rep 64:1353–1358

    Article  Google Scholar 

  3. Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A (2019) Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer 18:e87–e95

    Article  Google Scholar 

  4. Benson AB, Venook AP, Al-Hawary MM et al (2018) Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16:874–901

    Article  Google Scholar 

  5. Maas M, Beets-Tan RG, Lambregts DM et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633–4640

    Article  Google Scholar 

  6. Habr-Gama A, Perez RO, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717 discussion 7-8

    PubMed  PubMed Central  Google Scholar 

  7. Maas M, Nelemans PJ, Valentini V et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835–844

    Article  Google Scholar 

  8. Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 253:711–719

    Article  Google Scholar 

  9. Chadi SA, Malcomson L, Ensor J et al (2018) Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol 3:825–836

    Article  Google Scholar 

  10. Battersby NJ, How P, Moran B et al (2016) Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY II study. Ann Surg 263:751–760

    Article  Google Scholar 

  11. Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577

    Article  Google Scholar 

  12. Wu J, Tha KK, Xing L, Li R (2018) Radiomics and radiogenomics for precision radiotherapy. J Radiat Res 59:i25–i31

    Article  Google Scholar 

  13. Cui Y, Yang X, Shi Z et al (2019) Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 29:1211–1220

    Article  Google Scholar 

  14. Sun Y, Hu P, Wang J et al (2018) Radiomic features of pretreatment MRI could identify T stage in patients with rectal cancer: preliminary findings. J Magn Reson Imaging. https://doi.org/10.1002/jmri.25969

  15. Giannini V, Mazzetti S, Bertotto I et al (2019) Predicting locally advanced rectal cancer response to neoadjuvant therapy with (18)F-FDG PET and MRI radiomics features. Eur J Nucl Med Mol Imaging 46:878–888

    Article  CAS  Google Scholar 

  16. Shi L, Zhang Y, Nie K et al (2019) Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI. Magn Reson Imaging 61:33–40

    Article  Google Scholar 

  17. George TJ Jr, Allegra CJ, Yothers G (2015) Neoadjuvant rectal (NAR) score: a new surrogate endpoint in rectal cancer clinical trials. Curr Colorectal Cancer Rep 11:275–280

  18. Fokas E, Fietkau R, Hartmann A et al (2018) German Rectal Cancer Study G: neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. Ann Oncol 29:1521–1527

    Article  CAS  Google Scholar 

  19. Rosello S, Frasson M, Garcia-Granero E et al (2018) Integrating downstaging in the risk assessment of patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: validation of Valentini’s nomograms and the Neoadjuvant rectal score. Clin Colorectal Cancer 17:104–12 e2

    Article  Google Scholar 

  20. Sclafani F, Kalaitzaki E, Cunningham D, Tait D, Brown G, Chau I (2018) Neoadjuvant rectal score: run with the hare and hunt with the hounds. Ann Oncol 29:2261–2262

    Article  CAS  Google Scholar 

  21. Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19–23

    Article  CAS  Google Scholar 

  22. van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e1e7

    Article  Google Scholar 

  23. Zwanenburg A, Leger S, Agolli L et al (2019) Assessing robustness of radiomic features by image perturbation. Sci Rep 9:614

    Article  Google Scholar 

  24. Horvat N, Veeraraghavan H, Khan M et al (2018) MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology 287:833–843

    Article  Google Scholar 

  25. Jeon SH, Song C, Chie EK et al (2019) Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer. Radiat Oncol 14:43

    Article  Google Scholar 

  26. Zhou X, Yi Y, Liu Z et al (2019) Radiomics-based pretherapeutic prediction of non-response to neoadjuvant therapy in locally advanced rectal cancer. Ann Surg Oncol 26:1676–1684

    Article  Google Scholar 

  27. Braman NM, Etesami M, Prasanna P et al (2017) Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res 19:57

    Article  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiram Shaish.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Hiram Shaish, M.D.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• Retrospective

• diagnostic or prognostic study

• multicenter study

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 845 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shaish, H., Aukerman, A., Vanguri, R. et al. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study. Eur Radiol 30, 6263–6273 (2020). https://doi.org/10.1007/s00330-020-06968-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-020-06968-6

Keywords

Navigation